Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Miguel A. Suárez-Santisteban"'
Autor:
Miguel A. Suárez-Santisteban, Gracia Santos-Díaz, Vanesa García-Bernalt, Ana M. Pérez-Pico, Esther Mingorance, Raquel Mayordomo, Pedro Dorado
Publikováno v:
Nefrología (English Edition), Vol 44, Iss 3, Pp 382-395 (2024)
Background: There are evidence indicating that some metabolites of arachidonic acid produced by cytochromes P450 (CYP) and epoxide hydroxylase (EPHX2), such as hydroxyeicosatetraenoic acids (HETEs), epoxyeicosatrienoic acids (EETs) or dihydroxyeicosa
Externí odkaz:
https://doaj.org/article/56e945a50456488b8a3eb97acd953c8b
Autor:
Gracia Santos-Díaz, Ana María Pérez-Pico, Miguel Ángel Suárez-Santisteban, Vanesa García-Bernalt, Raquel Mayordomo, Pedro Dorado
Publikováno v:
Pharmaceutics, Vol 12, Iss 8, p 713 (2020)
Chronic kidney disease (CKD) is a major health problem worldwide and, in Spain, it is present in 15.1% of individuals. CKD is frequently associated with some comorbidities and patients need to be prescribed multiple medications. Polypharmacy increase
Externí odkaz:
https://doaj.org/article/dc9f6aba92004d6cae2ab22a44e03e1b
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 5; Pages: 782
Background: A promoter variable number tandem repeat polymorphism (pVNTR) of CYP2C9 is described with three types of fragments: short (pVNTR-S), medium (pVNTR-M) and long (pVNTR-L). The pVNTR-S allele reduces the CYP2C9 mRNA level in the human liver,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::000e60493fc33da687799df78bb56899
Autor:
Pedro, Dorado, Gracia, Santos-Díaz, Yolanda, Gutiérrez-Martín, Miguel Ángel, Suárez-Santisteban
Publikováno v:
Journal of personalized medicine. 12(5)
A promoter variable number tandem repeat polymorphism (pVNTR) ofA total of 209 subjects from Spain participated in the study. TheThe frequencies ofThe results from the present study show that both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::87ba131ff23be86918ce4c9d2904d02c
https://pubmed.ncbi.nlm.nih.gov/35629204
https://pubmed.ncbi.nlm.nih.gov/35629204
Autor:
Petra M. González Castillo, Inés Castellano Cerviño, Miguel Ángel Suárez Santisteban, Sandra Gallego Domínguez, Noura Gad
Publikováno v:
Diálisis y Trasplante. 30:89-92
Resumen Introduccion La hemodialisis supone la primera opcion de tratamiento renal sustitutivo en pacientes incidentes y la segunda, tras el trasplante renal, en pacientes prevalentes. Para su realizacion es imprescindible un acceso vascular que gara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21e91a1165fc0ac1ea90e0a353b654fb
https://doi.org/10.1016/s1886-2845(09)71935-6
https://doi.org/10.1016/s1886-2845(09)71935-6